New app for opioid use disorder shows the potential of digital therapies
In April 2018, Pear Therapeutics and Sandoz formed a commercialisation partnership for Pear’s...
Trending:
-
![]()
Tech giants are moving to transform the healthcare space
-
![reSET-O is an app for OUD]()
Sandoz and Pear Therapeutics get FDA clearance for reSET-O app
-
![Electrophysiology devices market growth]()
Cardiac electrophysiology set for explosive growth
-
![]()
RCS report highlights tech that will drive the future of surgery
-
![CRISPR babies ethics]()
CRISPR babies: an ethical framework is urgently needed
-
![future of medical cannabis]()
Can devices fill a gap in the blooming medical cannabis market?
Most Read
- Tech giants are moving to transform the healthcare space
- Bay Labs, Edwards Lifesciences sign AI heart disease detection deal
- Sandoz and Pear Therapeutics get FDA clearance for reSET-O app
- Cardiac electrophysiology set for explosive growth
- RCS report highlights tech that will drive the future of surgery
Company A-Z
Latest Content
New app for opioid use disorder shows the potential of digital therapies
In April 2018, Pear Therapeutics and Sandoz formed a commercialisation partnership for Pear’s leading pipeline assets, reSET and re-SET-O. The deal would combine Pear’s expertise in software-based therapeutics with Sandoz’s global reach and strong marketing force.
Tech giants are moving to transform the healthcare space
Major tech giants such as Amazon, Google, and Apple have all made moves to strategically position themselves to cash in on the immense opportunity present in the healthcare market.
Bay Labs, Edwards Lifesciences sign AI heart disease detection deal
Medical technology firm Bay Labs has partnered with medical equipment provider Edwards Lifesciences to bolster the detection of heart disease using artificial intelligence (AI) software.
Sandoz and Pear Therapeutics get FDA clearance for reSET-O app
Novartis subsidiary Sandoz and Pear Therapeutics have obtained US Food and Drug Administration (FDA) 510(k) clearance for the use of the reSET-O mobile application, which treats opioid use disorder (OUD).
Cardiac electrophysiology set for explosive growth
While currently relatively small at $4.6B this year, electrophysiology is expected to consistently grow at an extremely high rate of 4.60% in the foreseeable future, leading to a market size of $5.8B in five years.
Accumold: World Leaders in Micro-Mold Manufacturing Solutions
Accumold was founded in 1985. Our focus was to mold very small parts other companies could not produce. The same mission continues to drive us today.
RCS report highlights tech that will drive the future of surgery
The Royal College of Surgeons’ independent Commission on the Future of Surgery has predicted that surgery is set to be transformed for millions of patients due to an influx of new technologies.
CRISPR babies: an ethical framework is urgently needed
He Jiankui, a scientist and professor of biology at the Southern University of Science and Technology (SUSTech) in Shenzhen, Guangdong, China, has proclaimed the births of Nana and Lulu, the world’s first gene-edited babies. While this claim remains unverified by a third party, He posted a video to YouTube claiming that the genetic alterations were verified and that Nana and Lulu were healthy.
Subtle Medical gets FDA and CE-Mark clearances for imaging technology
Subtle Medical has received the US Food and Drug Administration (FDA) 510(k) clearance and the European CE-Mark for its imaging technology, called SubtlePET.
Can devices fill a gap in the blooming medical cannabis market?
With the legalisation of cannabis in Canada, interest has grown internationally, extending far beyond the North American borders into both Europe and Asia-Pacific.
Latest News
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Go Top
